NCT01546428View on ClinicalTrials.gov

A Phase I Study of INC280 in Japanese Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Advanced Solid Tumor
Interventions
DRUG

INC280

Trial Locations (2)

277-8577

Novartis Investigative Site, Kashiwa

811-1395

Novartis Investigative Site, Fukuoka

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY